Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Aspira Women’s Health ( (AWH) ) has issued an update.
Aspira Women’s Health Inc. experienced leadership changes in February 2025. Dr. Sandra Milligan resigned as President for personal reasons, effective February 21, 2025, with her responsibilities being assumed by Jamie Sullivan and Todd Pappas. Additionally, Ellen Beausang was appointed as a director on February 6, 2025, bringing over 25 years of experience from roles at BioReference Health, Pfizer, Thermo Fisher Diagnostics, and Quest Diagnostics. These changes may impact the company’s strategic direction and operational management.
More about Aspira Women’s Health
YTD Price Performance: -51.19%
Average Trading Volume: 92,396
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $6.2M
For an in-depth examination of AWH stock, go to TipRanks’ Stock Analysis page.